| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.
|
J Clin Endocrinol Metab
|
2005
|
3.43
|
|
2
|
Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects.
|
Am J Physiol Endocrinol Metab
|
2005
|
2.77
|
|
3
|
Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study.
|
Am J Clin Nutr
|
2011
|
2.47
|
|
4
|
Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects.
|
Mol Cell Endocrinol
|
2004
|
1.64
|
|
5
|
A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro.
|
Diabetes
|
2002
|
1.57
|
|
6
|
Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study.
|
Am J Physiol Endocrinol Metab
|
2010
|
1.46
|
|
7
|
Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue.
|
Am J Physiol Endocrinol Metab
|
2003
|
1.43
|
|
8
|
Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution.
|
J Clin Endocrinol Metab
|
2004
|
1.37
|
|
9
|
Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men.
|
Eur J Endocrinol
|
2003
|
1.26
|
|
10
|
Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study.
|
Eur J Endocrinol
|
2008
|
1.26
|
|
11
|
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss.
|
Eur J Endocrinol
|
2007
|
1.20
|
|
12
|
Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro.
|
Mol Cell Endocrinol
|
2002
|
1.18
|
|
13
|
Diet-induced weight loss and exercise alone and in combination enhance the expression of adiponectin receptors in adipose tissue and skeletal muscle, but only diet-induced weight loss enhanced circulating adiponectin.
|
J Clin Endocrinol Metab
|
2009
|
1.15
|
|
14
|
AICAR stimulates adiponectin and inhibits cytokines in adipose tissue.
|
Biochem Biophys Res Commun
|
2004
|
1.14
|
|
15
|
Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots.
|
Obesity (Silver Spring)
|
2006
|
1.13
|
|
16
|
Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels.
|
Am J Physiol Endocrinol Metab
|
2003
|
1.11
|
|
17
|
Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis.
|
Circulation
|
2004
|
1.07
|
|
18
|
Resveratrol in metabolic health: an overview of the current evidence and perspectives.
|
Ann N Y Acad Sci
|
2013
|
1.01
|
|
19
|
Weight loss maintenance in severely obese adults after an intensive lifestyle intervention: 2- to 4-year follow-up.
|
Obesity (Silver Spring)
|
2007
|
1.01
|
|
20
|
Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients.
|
Eur J Endocrinol
|
2004
|
0.99
|
|
21
|
Association between dietary glycemic index, glycemic load, and body mass index in the Inter99 study: is underreporting a problem?
|
Am J Clin Nutr
|
2006
|
0.97
|
|
22
|
The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss.
|
Obesity (Silver Spring)
|
2013
|
0.96
|
|
23
|
11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
|
Obesity (Silver Spring)
|
2007
|
0.96
|
|
24
|
Artificial sweeteners: a place in the field of functional foods? Focus on obesity and related metabolic disorders.
|
Curr Opin Clin Nutr Metab Care
|
2012
|
0.95
|
|
25
|
Comparable reduction of the visceral adipose tissue depot after a diet-induced weight loss with or without aerobic exercise in obese subjects: a 12-week randomized intervention study.
|
Eur J Endocrinol
|
2009
|
0.92
|
|
26
|
Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro.
|
Eur J Pharm Sci
|
2013
|
0.92
|
|
27
|
[Severe iron-deficiency anaemia after gastric bypass].
|
Ugeskr Laeger
|
2014
|
0.92
|
|
28
|
Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.
|
Clin Endocrinol (Oxf)
|
2009
|
0.92
|
|
29
|
Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet.
|
Nutr Res
|
2012
|
0.91
|
|
30
|
Opposite regulation of interleukin-8 and tumor necrosis factor-alpha by weight loss.
|
Obes Res
|
2002
|
0.91
|
|
31
|
Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
|
Metabolism
|
2009
|
0.90
|
|
32
|
[Hypoglycaemia after gastric bypass is a challenge to diagnostic procedures and treatment].
|
Ugeskr Laeger
|
2014
|
0.90
|
|
33
|
The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells.
|
Mol Cell Endocrinol
|
2008
|
0.89
|
|
34
|
Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy.
|
Metabolism
|
2006
|
0.89
|
|
35
|
Acute exercise increases circulating inflammatory markers in overweight and obese compared with lean subjects.
|
Eur J Appl Physiol
|
2013
|
0.87
|
|
36
|
Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index--a cross-sectional study.
|
J Pediatr
|
2004
|
0.87
|
|
37
|
Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.
|
J Clin Endocrinol Metab
|
2005
|
0.82
|
|
38
|
Anti-glucocorticoid effects of progesterone in vivo on rat adipose tissue metabolism.
|
Steroids
|
2003
|
0.81
|
|
39
|
Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
|
J Med Virol
|
2005
|
0.80
|
|
40
|
Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
|
Obesity (Silver Spring)
|
2008
|
0.79
|
|
41
|
Pro- and mature IGF-II during diet-induced weight loss in obese subjects.
|
Eur J Endocrinol
|
2005
|
0.79
|
|
42
|
Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV-lipodystrophy: implications for fat distribution.
|
Clin Endocrinol (Oxf)
|
2007
|
0.78
|
|
43
|
Ethanol exerts anti-inflammatory effects in human adipose tissue in vitro.
|
Mol Cell Endocrinol
|
2008
|
0.78
|
|
44
|
[Prevention and treatment of obesity in children].
|
Ugeskr Laeger
|
2006
|
0.78
|
|
45
|
Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial.
|
Obesity (Silver Spring)
|
2008
|
0.78
|
|
46
|
The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study.
|
Calcif Tissue Int
|
2013
|
0.78
|
|
47
|
[Prevention of obesity among children and adolescents--proposal for a strategy].
|
Ugeskr Laeger
|
2007
|
0.78
|
|
48
|
[Monitoring the prevalence of obesity].
|
Ugeskr Laeger
|
2008
|
0.77
|
|
49
|
Effects on food intake and blood lipids of cannabinoid receptor 1 antagonist treatment in lean rats.
|
Obesity (Silver Spring)
|
2008
|
0.76
|
|
50
|
The production and regulation of IGF and IGFBPs in human adipose tissue cultures.
|
Growth Horm IGF Res
|
2012
|
0.76
|
|
51
|
Sulfatide increases adiponectin and decreases TNF-alpha, IL-6, and IL-8 in human adipose tissue in vitro.
|
Mol Cell Endocrinol
|
2006
|
0.76
|
|
52
|
[Is there an obesity epidemic?].
|
Ugeskr Laeger
|
2005
|
0.75
|
|
53
|
Changes in Prescription Drug Use After Gastric Bypass Surgery: A Nationwide Cohort Study.
|
Ann Surg
|
2017
|
0.75
|
|
54
|
[Weight loss treatment of obese type 2 diabetic patients].
|
Ugeskr Laeger
|
2006
|
0.75
|
|
55
|
[Is Danish Christmas holiday compatible with healthy life style?].
|
Ugeskr Laeger
|
2003
|
0.75
|
|
56
|
[Measurement of body mass index and waist and hip circumference in adults].
|
Ugeskr Laeger
|
2009
|
0.75
|
|
57
|
[Economic and health: history about trans fatty acids].
|
Ugeskr Laeger
|
2004
|
0.75
|
|
58
|
[Severe hypoglycaemia and dumping syndrome after bariatric surgery].
|
Ugeskr Laeger
|
2014
|
0.75
|
|
59
|
[Obesity in Denmark--why has it not gone so badly?].
|
Ugeskr Laeger
|
2006
|
0.75
|
|
60
|
[Letigen, insulin resistance and treatment of obesity--again].
|
Ugeskr Laeger
|
2002
|
0.75
|
|
61
|
[The obese patient].
|
Ugeskr Laeger
|
2006
|
0.75
|
|
62
|
Intrahepatic fat content correlates with soluble CD163 in relation to weight loss induced by Roux-en-Y gastric bypass.
|
Obesity (Silver Spring)
|
2014
|
0.75
|
|
63
|
[Monogenetic obesity with special focus on the melanocortin 4 receptor gene mutations].
|
Ugeskr Laeger
|
2004
|
0.75
|
|
64
|
[Is there a future for medical treatment of obesity?].
|
Ugeskr Laeger
|
2009
|
0.75
|
|
65
|
Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.
|
J Endocrinol Invest
|
2014
|
0.75
|
|
66
|
[Occurrence of obesity: stagnation of the increase].
|
Ugeskr Laeger
|
2012
|
0.75
|
|
67
|
[Rare, severe hypersensitivity reaction to potassium iodide].
|
Ugeskr Laeger
|
2014
|
0.75
|
|
68
|
[Letigen, insulin resistance and treatment of obesity].
|
Ugeskr Laeger
|
2002
|
0.75
|
|
69
|
[Work-up and treatment of iron deficiency anaemia after bariatric surgery with gastric bypass].
|
Ugeskr Laeger
|
2014
|
0.75
|
|
70
|
[Weight history of patients with newly diagnosed type 2 diabetes--secondary publication].
|
Ugeskr Laeger
|
2008
|
0.75
|
|
71
|
[Central fat deposits contribute to atherosclerosis and insulin resistance and peripheral fat deposits protect against atherosclerosis and insulin resistance in postmenopausal women--secondary publication].
|
Ugeskr Laeger
|
2005
|
0.75
|
|
72
|
[Surgical treatment of severe obesity. The effect of laparoscopic adjustable gastric banding].
|
Ugeskr Laeger
|
2005
|
0.75
|
|
73
|
[Weight changes and the effect of anti-diabetes treatment in the first 5 years after diabetes diagnosis - secondary publication].
|
Ugeskr Laeger
|
2006
|
0.75
|
|
74
|
[Many complications after Roux-en-Y gastric bypass surgery can be prevented and treated].
|
Ugeskr Laeger
|
2016
|
0.75
|
|
75
|
[Physical activity is healthy--dietary supplements ad doping are not].
|
Ugeskr Laeger
|
2009
|
0.75
|